Mario Velasco practices Oncology. Mario Velasco is a published doctor and has 2 publications published. The lastest was: 'Cetuximab for the Treatment of Advanced Bronchioloalveolar Carcinoma (BAC): An Eastern Cooperative Oncology Group Phase II Study (ECOG 1504).' Mario Velasco accepts Medicare.
NPI NUMBER | 1326007782 | |
NPPES Provider LastName | VELASCO | |
NPPES Provider FirstName | MARIO | |
NPPES Provider ZIPCode | 62526 | |
NPPES Provider State | IL | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 1399.0 | |
Distinct Opioid Count | 6.0 | |
Opioid Claim Count | 173.0 | |
Percent Opioid Claims | 12.37 |
National Provider Identifier [NPI] | 1326007782 |
Last Name Of The Provider | VELASCO |
First Name Of The Provider | MARIO |
View All |
![]() |
Dr. Benjamin T. Esparaz, MD
![]() ![]() |
![]() |
Dr. Pramern Sriratana, MD
![]() |